Sources of polycyclic aromatic hydrocarbons are associated with gene-specific promoter methylation in women with breast cancer by White, Alexandra J. et al.
Environmental Research 145 (2016) 93–100Contents lists available at ScienceDirectEnvironmental Researchhttp://d
0013-93
n Corr
E-mjournal homepage: www.elsevier.com/locate/envresSources of polycyclic aromatic hydrocarbons are associated with
gene-specific promoter methylation in women with breast cancer
Alexandra J. White n,a, Jia Chen b,c,d, Susan L. Teitelbaum b, Lauren E. McCullough a,
Xinran Xu b,e, Yoon Hee Cho f, Kathleen Conway a, Jan Beyea g, Steven D. Stellman i,
Susan E. Steck l, Irina Mordukhovich a, Sybil M. Eng i, Mary Beth Terry i, Lawrence S. Engel a,
Maureen Hatchm, Alfred I. Neugut i,j, Hanina Hibshoosh k, Regina M. Santella h,
Marilie D. Gammon a
a Department of Epidemiology University of North Carolina, Chapel Hill, NC, USA
b Departments of Preventive Medicine, New York, NY, USA
c Departments of Oncological Science, New York, NY, USA
d Departments of Pediatrics, Ichan School of Medicine at Mt. Sinai, New York, NY, USA
e Departments of Biometrics, Roche Product Development in Asia-Pacific, Shanghai, China
f Department of Biomedical and Pharmaceutical Sciences, University of Montana, Missoula, MT, USA
g Department of Consulting in the Public Interest (CIPI), Lambertville, NJ, USA
h Departments of Environmental Health Sciences; Columbia University, New York, NY, USA
i Departments of Epidemiology, Columbia University, New York, NY, USA
j Departments of Medicine, Columbia University, New York, NY, USA
k Departments of Pathology and Cell Biology, Columbia University, New York, NY, USA
l Department of Epidemiology and Biostatistics, University of South Carolina, Columbia, SC, USA
m Departments of Division of Cancer Epidemiology and Genetics, Radiation Epidemiology Branch, National Cancer Institute, Bethesda, MD, USAa r t i c l e i n f o
Article history:
Received 12 October 2015
Received in revised form
24 November 2015







51/Published by Elsevier Inc.
esponding author.
ail address: whitea@unc.edu (A.J. White).a b s t r a c t
Background: Tobacco smoke, diet and indoor/outdoor air pollution, all major sources of polycyclic aro-
matic hydrocarbons (PAHs), have been associated with breast cancer. Aberrant methylation may be an
early event in carcinogenesis, but whether PAHs influence the epigenome is unclear, particularly in
breast tissue where methylation may be most relevant. We aimed to evaluate the role of methylation in
the association between PAHs and breast cancer.
Methods: In a population-based case-control study, we measured promoter methylation of 13 breast
cancer-related genes in breast tumor tissue (n¼765–851 cases) and global methylation in peripheral blood
(1055 cases/1101 controls). PAH sources (current active smoking, residential environmental tobacco smoke
(ETS), vehicular traffic, synthetic log burning, and grilled/smoked meat intake) were evaluated separately.
Logistic regression was used to estimate adjusted odds ratios (ORs) and 95% confidence intervals (CIs).
Results: When comparing methylated versus unmethylated genes, synthetic log use was associated with
increased ORs for CDH1 (OR¼2.26, 95%CI¼1.06–4.79), HIN1 (OR¼2.14, 95%CI¼1.34–3.42) and RARβ
(OR¼1.80, 95%CI¼1.16–2.78) and decreased ORs for BRCA1 (OR¼0.44, 95%CI¼0.30–0.66). Residential ETS
was associated with decreased ORs for ESR1 (OR¼0.74, 95%CI¼0.56–0.99) and CCND2 methylation
(OR¼0.65, 95%CI¼0.44–0.96). Current smoking and vehicular traffic were associated with decreased ORs
for DAPK (OR¼0.53, 95%CI¼0.28–0.99) and increased ORs for TWIST1 methylation (OR¼2.79, 95%
CI¼1.24–6.30), respectively. In controls, synthetic log use was inversely associated with LINE-1 (OR¼0.59,
95%CI¼0.41–0.86).
Discussion: PAH sources were associated with hypo- and hypermethylation at multiple promoter regions
in breast tumors and LINE-1 hypomethylation in blood of controls. Methylation may be a potential bio-
logic mechanism for the associations between PAHs and breast cancer incidence.
Published by Elsevier Inc.1. Introduction
Polycyclic aromatic hydrocarbons (PAHs) are established car-
cinogens to the lung (IARC, 2010), but their relationship with
A.J. White et al. / Environmental Research 145 (2016) 93–10094breast cancer is not as well studied. PAH biomarkers, which tend
to reflect recent exposure, have been associated with breast cancer
incidence (Gammon et al., 2004b). Additionally, PAHs induce
mammary tumors in laboratory animals (Hecht, 2002). PAHs are
ubiquitous pollutants that form as a combustion by-product of
organic material (Boström et al., 2002). The major sources of PAH
in the general population are indoor and outdoor air pollution,
tobacco smoke and diet (Boström et al., 2002). Elevated associa-
tions with breast cancer incidence have been observed with the
main sources of PAH exposure, including active cigarette smoking
(Gaudet et al., 2013), long-term environmental tobacco smoke
(ETS) (Gammon et al., 2004a; Morabia et al., 1996), indoor air
pollution from burning synthetic logs (White et al., 2014), outdoor
air pollution (Hystad et al., 2015; Mordukhovich et al., 2015; Nie
et al., 2007), and intake of grilled and smoked foods (Fu et al.,
2011; Steck et al., 2007).
Aberrant DNA methylation, an epigenetic modification, plays an
important role in breast carcinogenesis (Xu et al., 2011; Xu et al.,
2012). Higher levels of methylation at promoter regions can si-
lence tumor suppressor genes and tumor tissue may be were
methylation is most relevant (Jones, 2012). Our research team has
reported that methylation at promoter regions of specific genes in
breast tumor tissue is associated with breast cancer clinical/pa-
thological factors and mortality in a population-based sample (Cho
et al., 2012). In contrast, lower levels of global methylation may
confer genomic instability and increased mutation rates (Brennan
and Flanagan, 2012). Although the associations between cancer
and global methylation have been inconclusive (Brennan and
Flanagan, 2012), our research group has previously reported an
association with breast cancer for luminometric methylation assay
(LUMA), but not for methylation of long interspersed elements-1
(LINE-1) in white blood cells (Xu et al., 2012). DNA methylation
may be altered in response to environment and lifestyle factors
and may be a potential biologic mechanism for disease (Bollati and
Baccarelli, 2010). Other investigators have found that exposure to
the PAH sources of tobacco smoke and air pollution may be as-
sociated with changes in DNA methylation patterns (Duan et al.,
2013; Shenker et al., 2013).
For the current study, we aimed to better understand the role
methylation plays in the PAH and breast cancer association.
We first aimed to examine whether five individual PAH sources,
previously found to be modestly associated with breast cancer
incidence (current active cigarette smoking (Gammon et al.,
2004a), long-term residential ETS (Gammon et al., 2004a),
total grilled/smoked food intake (Steck et al., 2007), residential
burning of synthetic logs (White et al., 2014) and high vehicular
traffic exposure (Mordukhovich et al., 2015)), were also associated
with promoter methylation status in a panel of 13-breast
cancer related genes measured in the tumor tissue of a popula-
tion-based sample of women with breast cancer. We also aimed
to investigate whether these same PAH sources were associated
with global methylation in a population-based sample of
women without breast cancer, using two independent global
methylation markers, LINE-1 and LUMA, measured in peripheral
blood DNA.2. Materials and methods
Our study builds upon population-based resources from the
Long Island Breast Cancer Study Project (LIBCSP). The parent
LIBCSP methods have been previously published in detail (Gam-
mon et al., 2002). Institutional Review Board approval was ob-
tained from all relevant institutions.2.1. Study population
Study participants included 1508 breast cancer cases and 1,556
controls who were English-speaking women residing in Nassau
and Suffolk counties on Long Island, New York. Written informed
consent was obtained from all study participants.
Cases were women who had been recently diagnosed with a
first primary in situ or invasive breast cancer between August 1st,
1996 and July 31st, 1997, and were residents of Nassau or Suffolk
counties on Long Island, New York (NY). There were no age or race
restrictions for case eligibility. Cases were identified using rapid
case ascertainment from the pathology departments of all 28
hospitals on Long Island and three tertiary care hospitals in New
York City. Diagnoses were confirmed by the physician or the
medical record.
Controls had no prior history of breast cancer and were fre-
quency matched in 5-year age groups to cases based on the ex-
pected age distribution of case women. Controls were identified in
1996–1997 from among adult female residents of Nassau and
Suffolk counties in NY using random digit dialing for those who
were less than 65 years of age, and for those who were 65 years of
age and greater, using the Health Care Finance Administration
rosters.
Study participants ranged in age from 20–98 years, and most
cases and controls were postmenopausal (68.1% and 66.3%, re-
spectively) and identified themselves as white (93.8% and 91.8%,
respectively); the racial distribution of our population-based
sample reflects that of Nassau and Suffolk counties at the time of
data collection (Gammon et al., 2002). Cases and controls had si-
milar distributions of education and income (Gammon et al.,
2002), and the median age at menarche was also similar (12.6
years, standard deviation (SD)¼1.67; and 12.6 years, SD¼1.65,
respectively). On average, controls were more likely to be parous
than cases (89.0% versus 86.9%, respectively) (Gammon et al.
2002). Some 10% of cases and 8% of controls reported drinking 1–2
glasses per day (15–30 g) of alcohol, on average across the life
course (Terry et al. 2006).
2.2. PAH exposure sources assessment
Five PAH exposure sources were assessed. Current active
smoking, residential ETS, grilled/smoked meat intake, and syn-
thetic log burning were assessed by a trained interviewer using a
structured questionnaire (Gammon et al., 2004a; Steck et al., 2007;
White et al., 2014); and vehicular traffic exposure was assessed by
a validated historical geographic model (Beyea et al., 2006; Mor-
dukhovich et al., 2015). Detailed LIBCSP PAH source assessment
methods have been previously published (Gammon et al., 2004a;
Mordukhovich et al., 2015; Steck et al., 2007; White et al., 2014).
The PAH variable definitions, based on previous published asso-
ciations with breast cancer, and total sample sizes used in the
study reported here are described below.
Current active smoking (yes, no) was defined as smoking
within the 12 months prior to the reference date, which was date
of diagnosis for cases and date of identification for controls
(n¼1553 controls/1508 cases) (Gammon et al. 2004a). Participants
were asked if they had lived with a smoking spouse to determine
residential ETS exposure (yes, no) (n¼1515 controls/1468 cases)
(Gammon et al., 2004a). Frequency of grilled/smoked meat intake
was assessed for each of six decades across the life course, or fewer
depending on age at diagnosis (Steck et al., 2007). Lifetime intake
was defined as the average servings consumed per year based on
quantile distributions in the controls (o33% vs Z33% percentile
or o55 servings/year, 55þ servings/year) (n¼1515 controls/1468
cases) (Steck et al., 2007). Residential stove and fireplace use was
defined as using a stove/fireplace in a Long Island residence for at
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synthetic logs (yes, no) (n¼1541 controls/1501 cases) (White et al.,
2014). A geographic model estimated vehicular traffic exposure for
the study participant’s residence in 1995 by incorporating histor-
ical United States (U.S.) vehicular PAH emissions data, information
on traffic and transportation patterns, Long Island, NY meteor-
ological variables and pollutant dispersion factors (o95th per-
centile, Z95th percentile) (n¼1334 controls/1274 cases) (Mor-
dukhovich et al., 2015). This cutpoint was previously found to best
represent the association with breast cancer incidence (Mordu-
khovich et al., 2015).
As a sensitivity analysis, more refined exposure classifications
for current active smoking (no current, currento20 pack-years,
current 20þpack-years), spouse ETS exposure in months (tertiles),
grilled/smoked meat intake (tertiles) and vehicular traffic (o50th
percentile, 50–75th percentile, 75–95th percentile, 95th percen-
tile) were also evaluated.
2.3. Gene-specific promoter DNA methylation assessment
Promoter methylation status was measured in tumor tissue for
a panel of 13 breast cancer-related genes [adenomatous polyposis
coli (APC), breast cancer 1, early onset (BRCA1), cyclin D2 (CCND2),
E-Cadherin (CDH1), death-associated protein kinase 1 (DAPK1), es-
trogen receptor 1 (ESR1), glutathione S-transferase pi 1 (GSTP1), se-
cretoglobin, family 3A, member 1 (HIN1), cyclin-dependent kinase
inhibitor 2A (CDKN2A), progesterone receptor (PGR), retinoic acid
receptor, beta (RARβ, Ras association domain family member 1
(RASSF1A) and twist homolog 1 (TWIST1)]. These genes are known
to play an important role in breast carcinogenesis and their pro-
moter regions are frequently methylated in breast tumor tissues
(Xu et al., 2011). Methylation at certain CpG sites may vary by
biologic sample type (Jones, 2012) and the measurement of gene-
specific methylation in the tumor tissue is more sensitive than
measuring the same sites in circulating blood DNA (Brooks et al.,
2009).
The methods used to determine gene-specific promoter me-
thylation status have been previous published and are briefly de-
scribed below (Xu et al., 2011; Xu et al., 2012). DNA was extracted
from tumor blocks, as described in previously published methods
(Xu et al., 2009). To determine methylation levels for ESR1, PGR
and BRCA1, methylation-specific PCR was used (Liu et al., 2003; Xu
et al., 2009). The gene was determined to be methylated or not
methylated based on whether PCR product was obtained using
methylation-specific primers. Thus, ESR1, PGR and BRCA1 are di-
chotomous variables (methylated vs. unmethylated), as de-
termined by the assay. Once it became available, the quantitative
MethyLight assay was used to measure the methylation status of
the remaining 10 genes (Eads et al., 1999; Eads et al., 2000a). Bi-
sulfite-converted genomic DNA was amplified using a fluores-
cence-based, real-time quantitative PCR which results in a per-
centage methylated (Chomczynski and Sacchi, 1987; Gibson et al.,
1996). Continuous values were dichotomized (o4%, Z4% me-
thylated) to be consistent with previous published reports by our
study team and others (Eads et al., 2000a; Xu et al., 2011). This
Z4% cutpoint for the MethyLight assay has been previously re-
ported to distinguish between malignant and normal tissues and is
indicative of repressed gene expression (Eads et al., 2000b; Ogino
et al., 2006). Number of case samples completed and percent
methylated for each promoter in LIBCSP have been previously re-
ported (n¼765–851 and percent methylation 3.6–62.9%) (Xu et al.,
2011).
2.4. Global methylation assessment
Two complimentary, but independent, methods were used toassess global methylation levels in DNA extracted from blood
samples, LINE-1 and LUMA (1055 cases/1101 controls) (Xu et al.,
2012). The LINE-1 assay is a measure of methylation at repetitive
elements as a proxy measure of overall global methylation and it is
hypothesized that lower methylation at LINE-1 may indicate in-
creased chromosomal instability and likelihood of mutations
(Brennan and Flanagan, 2012). In contrast, the LUMA measure
summarizes methylation levels (5-mC) at all “CCGG” sequences
and thus, may be considered more representative of gene-specific
methylation (Brennan and Flanagan, 2012).
The LINE-1 assay was completed using a prevalidated pyr-
osequencing assay to assess 4 CpG sites in the promoter of LINE-1
at EpigenDx (Worcester, MA, USA) as described previously (Xu
et al., 2012). Methylation status at each of the 4 CpG loci was
analyzed individually as a T/C single nucleotide polymorphism
(SNP) using QCpG software (Qiagen). Methylation status data at all
4 loci were averaged to provide an overall percent 5-mC status. The
LUMA assay is expressed as a percentage obtained using the fol-
lowing equation (Bjornsson et al., 2008): methylation (%)¼((1
(HpaII∑G/∑T)/(MspI∑G/∑T)*100)).
2.5. Hormone receptor subtype
Breast cancer subtype for the first primary was defined by es-
trogen/progesterone receptor status (ER/PR) obtained from the
medical record, and was available for 65.6% of cases (n¼990)
(Gammon et al., 2002).
2.6. Statistical analysis
All analyses were completed using SAS 9.3 (Cary, NC). To in-
vestigate whether the five PAH sources, considered separately,
were associated with methylation levels, we used unconditional
logistic regression to estimate odds ratios (ORs) and corresponding
95% confidence intervals (CIs). Multiplicative interaction was as-
sessed by comparing multivariable models with and without
cross-product terms to denote the interaction using an a priori
alpha level of 0.05.
For examining gene-specific promoter methylation, we used a
case-case approach to determine whether PAH source exposures
were associated with methylation in tumor tissue. Tumor subtypes
were defined as methylated versus non-methylated. If the gene-
specific promoter sample size within a stratum was less than 5, it
was no longer included in the analysis. We explored whether the
association between sources of PAH and gene-specific promoter
methylation varied by hormone receptor status by testing for a
multiplicative interaction between the PAH source, gene-promoter
methylation and ER/PR status of the tumor.
For examining global methylation, we first used a controls-only
approach to assess whether PAH sources were associated with
LINE-1 or LUMA measured in control blood samples. LINE-1 and
LUMA levels were dichotomized based on the distribution in the
controls as neither LINE-1 nor LUMA were normally distributed
before or after natural log transformation. We subsequently uti-
lized a case-control approach to assess whether the relationship
between PAH sources and breast cancer incidence was modified by
LUMA and/or LINE-1, on a multiplicative scale using both the
continuous variable and the dichotomized variable. For the study
reported here, global methylation assay results among cases are
based on blood samples donated prior to chemotherapy (n¼79%).
Additionally, in order to compare our results with previous re-
search (Pirouzpanah et al., 2010; Tao et al., 2014), we conducted a
sensitivity analysis to determine if LUMA was associated with
wood-burning in the controls and if ever smoking was associated
with gene-specific methylation in the tumor of cases.
Confounders were identified using a directed acyclic graph
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(o12, Z12); parity (nulliparous, parous); lifetime alcohol intake
(non-drinkers, o15 g/day, 15–30 g/day, Z30 g/day); education
(high school graduate or less, some college, college graduate);
income (o$34,999, $35,000-$69,999, Z$70,000); and the fre-
quency matching factor, 5-year age group.3. Results
3.1. Gene-specific promoter methylation in tumor tissue
Results for the associations between each individual source of
PAH exposure and the 13 gene-specific methylation markers are
shown in Tables 1–5, respectively. ORs greater than 1 indicate
increased odds of methylation and ORs less than 1 indicate de-
creased odds of methylation. There were similarities in associa-
tions between the gene-specific DNA methylation measured in
tumor tissue and the PAH sources (Tables 1–5). For example, ORs
for CCND2 methylation were reduced for residential ETS (Table 2;
OR¼0.65, 95%CI¼0.44–0.96) and perhaps for high grilled/smoked
meat intake (Table 1; OR¼0.69, 95%CI¼0.46–1.06), although
confidence intervals for the latter included the null value. ORs for
RARβ methylation were elevated in association with burning of
synthetic logs (Table 4; OR¼1.80, 95%CI¼1.16–2.78) and for high
grilled/smoked meat intake (Table 1; OR¼1.39, 95%CI¼0.94–2.08).
ORs for BRCA1 were reduced, indicating hypomethylation in as-
sociation with synthetic logs use (OR¼0.44, 95%CI¼0.30–0.66),
and perhaps with current active smoking (OR¼0.74, 95%CI¼0.52–
1.07), although the confidence intervals for the latter included the
null value (Tables 3 and 4, respectively).
Additionally, current active smoking was associated with lower
odds of DAPK methylation (OR¼0.53, 95%CI¼0.28–0.99) (Table 3)
although no other associations with DAPK were evident. Lower
odds of ESR1 methylation was observed in association with re-
sidential ETS (OR¼0.74, 95%CI¼0.56–0.99) (Table 2). Synthetic log
use was associated with elevated odds of HIN1 methylation
(OR¼2.14, 95%CI¼1.34–3.42) and CDH1 methylation (OR¼2.26,
95%CI¼1.06–4.79) (Table 4). Vehicular traffic was associated with
higher odds of TWIST1 methylation (OR¼2.79, 95%CI¼1.24–6.30)
(Table 5).
Ever active smoking, while not included in our a priori ex-
posures of interest, was additionally found to be associated with
decreased odds of methylation of ESR1 (OR¼0.69, 95%CI 0.52–
0.92) and HIN1 (OR¼0.66, 95%CI 0.48–0.91) (Appendix Table 1).Table 1
Odds of gene specific promoter methylation in tumor of cases in association with avera
No active smoking
Genes Unmethylated (N) Methylated (N) OR (95%CI)
ESR1 187 187 1.00(reference
PGR 327 51 1.00(reference
BRCA1 149 229 1.00(reference
APC 186 166 1.00(reference
CDKN2A 329 14 1.00(reference
HIN1 107 223 1.00(reference
RASSF1a 47 283 1.00(reference
DAPK1 284 46 1.00 (referenc
GSTP1 233 97 1.00(reference
CCND2 272 58 1.00(reference
TWIST1 279 51 1.00(reference
CDH1 311 19 1.00(reference
RARβ 236 94 1.00(reference
15–30 g/day, Z30 g/day), education (high school graduate or less, some college, college
factor, 5-year age group.
a Adjusted for age at menarche (o12, Z12 years), parous (nulliparous, parous), lifeWe did not observe any evidence of effect measure modification of
the association between PAH sources and gene-specific methyla-
tion by hormone receptor status of the tumor (data not shown).
3.2. Global methylation in peripheral blood
Synthetic log use in the home was associated with hypo-
methylation of LINE-1 in controls (OR¼0.59, 95%CI¼0.41–0.86)
and suggestively associated with a pattern of hypomethylation in
the LUMA assay (OR¼0.75, 95%CI¼0.52–1.09) (Appendix Table 2).
None of the other PAH sources, including indoor wood burning in
a stove or fireplace (data not shown), were associated with either
LINE-1 or LUMA. We did not observe any evidence of effect mea-
sure modification of the association between the PAH sources and
breast cancer incidence by global methylation markers (Appendix
Tables 3 and 4), or tumor heterogeneity considering hormone re-
ceptor status of the tumor (data not shown) with either con-
tinuous or dichotomized global methylation variables.
3.3. Sensitivity analyses
For both global and gene-specific analyses, more refined ex-
posure classifications for the PAH sources were considered. All
results and conclusions remained the same (data not shown) and
therefore the results for the dichotomized PAH exposure sources
were included here as they best represented associations and
functioned to maximize power.4. Discussion
The sources of PAH exposure examined here were associated
with a number of methylation sites in both the gene-specific tu-
mor of cases and the blood of controls supporting the hypothesis
that DNA methylation may be one of the potential biologic me-
chanisms for the association between PAH sources and breast
cancer. We considered sources of PAH exposure, and classifications
of exposure, based on our previous studies (Gammon et al., 2004a;
Mordukhovich et al., 2015; Steck et al., 2007; White et al., 2014)
and others (Fu et al., 2011; Gaudet et al., 2013; Hystad et al., 2015;
Morabia 2002), with breast cancer incidence. Thus, many of the
associations with DNA methylation observed among our popula-
tion-based sample of women with breast cancer are biologically
plausible and relevant for breast carcinogenesis. For example, we
observed decreased methylation in the tumor of CCND2, ange lifetime intake of grilled/barbecued/smoked meat intake, LIBCSP 1996–1997a.
Ever active smoking
Unmethylated (N) Methylated (N) OR (95%CI)
) 273 196 0.69(0.52, 0.92)
) 422 51 0.87(0.56, 1.35)
) 198 275 0.93(0.69, 1.24)
) 227 221 1.04(0.78, 1.40)
) 418 16 0.75(0.34, 1.64)
) 177 258 0.66(0.48, 0.91)
) 66 369 0.99(0.65, 1.53)
e) 373 62 0.96(0.62, 1.49)
) 319 116 0.84(0.60, 1.18)
) 343 92 1.33(0.90, 1.98)
) 370 65 0.95(0.62, 1.46)
) 410 25 0.85(0.44, 1.63)
) 318 117 0.90(0.64, 1.26)
or post-college), income (o$34,999,$35,000–69,999, Z$70,000) and the matching
time alcohol intake (non-drinkers, o15 g/day).
Table 2
Odds of gene specific promoter methylation in tumor of cases in association with long-term residential environmental tobacco smoke (ETS), LIBCSP 1996–1997a.
No residential ETS Residential ETS
Genes Unmethylated (N) Methylated (N) OR (95%CI) Unmethylated (N) Methylated (N) OR (95%CI)
ESR1 210 195 1.00(reference) 241 173 0.74(0.56, 0.99)
PGR 358 51 1.00(reference) 369 48 1.00(0.64, 1.56)
BRCA1 166 243 1.00(reference) 174 243 1.03(0.77, 1.39)
APC 203 183 1.00(reference) 199 192 1.01(0.75, 1.36)
CDKN2A 364 13 1.00(reference) 361 16 0.97(0.44, 2.14)
HIN1 130 226 1.00 (reference) 142 244 1.02(0.74, 1.41)
RASSF1a 48 308 1.00(reference) 63 323 0.83(0.53, 1.28)
DAPK1 309 47 1.00(reference) 329 57 1.05(0.67, 1.62)
GSTP1 255 101 1.00(reference) 281 105 0.91(0.65, 1.28)
CCND2 279 77 1.00(reference) 318 68 0.65 (0.44, 0.96)
TWIST1 298 58 1.00(reference) 329 57 0.89(0.58, 1.36)
CDH1 335 21 1.00(reference) 364 22 0.86(0.45, 1.67)
RARβ 254 102 1.00(reference) 283 103 0.86(0.61, 1.21)
15–30 g/day, Z30 g/day), education (high school graduate or less, some college, college or post-college), income (o$34,999,$35,000–69,999, Z$70,000) and the matching
factor, 5-year age group.
a Adjusted for age at menarche (o12, Z12 years), parous (nulliparous, parous), lifetime alcohol intake (non-drinkers, o15 g/day).
A.J. White et al. / Environmental Research 145 (2016) 93–100 97oncogene, in association with residential ETS. Lower methylation
at some CpGs in CCND2 is correlated with increased mRNA ex-
pression in The Cancer Genome Atlas (TCGA) breast tumor data
(Gao et al., 2013). Conversely, we observed increased methylation
for RARβ, HIN1 and CDH1 in association with the sources of PAH
exposure. Both HIN1 and CDH1 are tumor suppressor genes, and
increased methylation levels are associated with decreased ex-
pression of these genes in TCGA data(Gao et al., 2013). Decreased
expression of RARβ, a steroid hormone receptor that is important
for maintaining normal cell growth and regulation, has also been
found to play a role in breast carcinogenesis (Pirouzpanah et al.,
2010). Thus, PAH sources may be both increasing expression of
oncogenes and repressing expression of tumor suppressor and
other genes important for normal cell functioning.
We observed that PAH sources were associated with DNA
methylation in similar directions at certain gene promoter regions,
despite differences in exposure source or even route of exposure.
For example, we reported decreased ORs for methylation at CCND2
for both residential ETS and grilled/smoked meat intake. This
pattern of findings is supportive of similar biologic mechanisms
across the exposure sources. We observed either increased or
decreased ORs for methylation across different genes, which is
consistent with other epidemiologic studies of active smoking in
healthy individuals that have found associations with bothTable 3
Odds of gene specific promoter methylation in tumor of cases in association with curre
No current active smoking
Genes Unmethylated (N) Methylated (N) OR (95%CI)
ESR1 369 309 1.00 (referenc
PGR 601 84 1.00 (referenc
BRCA1 269 416 1.00 (referenc
APC 333 306 1.00 (referenc
CDKN2A 598 24 1.00 (referenc
HIN1 224 338 1.00 (referenc
RASSF1a 86 526 1.00 (referenc
DAPK1 517 95 1.00 (referenc
GSTP1 329 173 1.00 (referenc
CCND2 491 121 1.00 (referenc
TWIST1 517 95 1.00 (referenc
CDH1 578 34 1.00 (referenc
RARβ 442 170 1.00 (referenc
15–30 g/day, Z30 g/day), education (high school graduate or less, some college, college
factor, 5-year age group.
a Adjusted for age at menarche (o12, Z12 years), parous (nulliparous, parous), lifeincreases and decreases in methylation that are site-specific (Zei-
linger et al., 2013; Zhang et al., 2014). Similarly, a study in breast
cancer cell lines found that treatment with the PAH compound
benzo[a]pyrene (BaP) induces both hyper- and hypomethylation at
different sites (Sadikovic and Rodenhiser, 2006). Although the
mechanisms for the association between PAHs and DNA methy-
lation are not completely understood, there are a number of pos-
sible mechanisms by which PAHs may disturb DNA methylation
patterns resulting in both increases and reductions in methylation
levels. There is evidence that a BaP metabolite, benzo(a)pyrene
diolepoxide (BPDE), has enhanced binding to DNA at methylated
CpG sites (Yoon et al., 2001) and that DNA methyltransferase bind
to DNA lesions with high affinity when there is DNA damage such
as that from carcinogenic adducts (James et al., 2003). Ad-
ditionally, BPDE can inhibit the function of methyltransferase en-
zymes resulting in a loss of methylation (Wilson and Jones, 1984).
It is also possible that methylation may be lost during the repair of
carcinogenic adducts from PAH exposure via the nucleotide exci-
sion repair pathway (Holliday, 1979). Repair of these damaged
regions could lead to hypomethylation if methylation is not re-
gained prior to DNA replication (Sadikovic and Rodenhiser, 2006).
In addition to our findings with gene-specific methylation,
exposure to burning synthetic logs was found to be associated
with LINE-1 hypomethylation in the peripheral blood among ournt active smoking, LIBCSP 1996–1997a.
Current active smoking
Unmethylated (N) Methylated (N) OR (95%CI)
e) 91 74 0.94(0.66, 1.35)
e) 148 18 0.94(0.54, 1.66)
e) 78 88 0.74(0.52, 1.07)
e) 80 81 1.09(0.76, 1.57)
e) 149 6 0.81(0.30, 2.14)
e) 60 93 0.81(0.55, 1.20)
e) 27 126 0.70(0.42, 1.15)
e) 140 13 0.53(0.28, 0.99)
e) 113 40 0.82(0.53, 1.24)
e) 124 29 1.12(0.69, 1.81)
e) 132 21 0.96(0.56, 1.65)
e) 143 10 1.07(0.50, 2.34)
e) 112 41 0.94(0.62, 1.44)
or post-college), income (o$34,999,$35,000–69,999, Z$70,000) and the matching
time alcohol intake (non-drinkers, o15 g/day).
Table 4
Odds of gene specific promoter methylation in tumor of cases in association with residential burning of synthetic logs, LIBCSP 1996–1997a.
No synthetic log use Synthetic log use
Genes Unmethylated (N) Methylated (N) OR (95%CI) Unmethylated (N) Methylated (N) OR (95%CI)
ESR1 381 325 1.00 (reference) 79 56 0.80(0.55, 1.19)
PGR 625 87 1.00 (reference) 121 15 0.82(0.45, 1.50)
BRCA1 270 442 1.00 (reference) 75 62 0.44(0.30, 0.66)
APC 347 322 1.00 (reference) 65 64 1.04(0.70, 1.55)
CDKN2A 624 25 1.00 (reference) 121 5 1.03(0.37, 2.87)
HIN1 256 394 1.00 (reference) 28 86 2.14(1.34, 3.42)
RASSF1a 101 549 1.00 (reference) 12 102 1.68(0.87, 3.24)
DAPK1 559 91 1.00 (reference) 97 17 1.13(0.63, 2.03)
GSTP1 473 177 1.00 (reference) 78 36 1.30(0.83, 2.03)
CCND2 523 127 1.00 (reference) 91 23 1.20(0.72, 2.03)
TWIST1 551 99 1.00 (reference) 97 17 1.03(0.58, 1.85)
CDH1 617 33 1.00 (reference) 103 11 2.26(1.06, 4.79)
RARβ 480 170 1.00 (reference) 73 41 1.80(1.16, 2.78)
15–30 g/day, Z30 g/day), education (high school graduate or less, some college, college or post-college), income (o$34,999,$35,000–69,999, Z$70,000) and the matching
factor, 5-year age group.
a Adjusted for age at menarche (o12, Z12 years), parous (nulliparous, parous), lifetime alcohol intake (non-drinkers, o15 g/day).
A.J. White et al. / Environmental Research 145 (2016) 93–10098population-based sample of women without breast cancer. LINE-1
hypomethylation in the peripheral blood, hypothesized to indicate
chromosomal instability and increased likelihood for mutations,
has been found to be associated with breast cancer in a pro-
spective cohort (Deroo et al., 2014), although such an association
was not observed in the LIBCSP (Xu et al., 2012). BaP has also been
found to decrease global methylation in vitro (Wilson and Jones,
1983). In contrast to our null findings reported here for the LIBCSP
population, a study conducted in Warsaw, Poland reported an in-
verse association between indoor air pollution measured by wood
and coal burning with peripheral blood global methylation mea-
sured by LUMA (Tao et al., 2014). However, the investigators of the
Polish study did not consider synthetic log burning which is likely
less commonly used in their study population.
Several issues regarding our PAH source measures may impact
our study interpretation. We selected the PAH source variables
included here because each was previously reported to be most
relevant to breast cancer incidence in our study population
(Gammon et al., 2004a; Mordukhovich et al., 2015; Steck et al.,
2007; White et al., 2014). However, other PAH source classifica-
tions (e.g., ever or former smokers) and other time frames of ex-
posures may also be relevant for methylation alterations (Shenker
et al., 2013). Our study design limited our ability to isolate specific
PAH carcinogens, yet the PAH carcinogens found in each exposureTable 5
Odds of gene specific promoter methylation in tumor of cases in association with vehic
Low vehicular traffic (o95th percentile)
Genesb Unmethylated (N) Methylated (N) OR (95%CI)
ESR1 354 310 1.00(reference
PGR 594 77 1.00(reference
BRCA1 273 398 1.00(reference
APC 327 307 1.00(reference
HIN1 221 376 1.00(reference
RASSF1a 88 509 1.00(reference
DAPK1 515 82 1.00(reference
GSTP1 431 166 1.00(reference
CCND2 482 115 1.00(reference
TWIST1 520 77 1.00(reference
RARβ 433 164 1.00(reference
15–30 g/day, Z30 g/day), education (high school graduate or less, some college, college
factor, 5-year age group.
a Adjusted for age at menarche (o12, Z12 years), parous (nulliparous, parous), life
b CDKN2A and CDH1 had cell sizes less than 5 and odds ratios were not estimated.source are known to vary (Boström et al., 2002). Also, the PAH
exposure sources considered here contain other chemicals (IARC
2010). These variations across exposure sources, however, could be
relevant to DNA methylation changes and may be reasons for some
discrepancy in patterns across methylated sites among studies and
PAH sources (Ruiz-Hernandez et al., 2015).
In our population-based sample of women, who were ambi-
ently exposed to PAH from multiple sources, we were able to
consider both gene-specific and global methylation with a number
of PAH exposure sources, specifically focusing on those which our
study team has previously found to be associated with breast
cancer. We were also able to evaluate potential heterogeneity by
hormone receptor subtype, as methylation level at a given locus
may be particularly associated with specific breast cancer tumor
subtypes over others (Avraham et al., 2014). Consideration of tu-
mor subtype did not alter our conclusions, possibly because the
LIBCSP study population is predominately women with hormone
receptor positive tumors and therefore, power to assess associa-
tions in receptor negative tumors was limited (Gammon et al.,
2004a).
Few previous studies have considered associations between
tobacco smoke and DNA methylation in breast cancer tissue; one
study found ever smoking to be associated with ESR1 hy-
permethylation in breast tissue of Iranian women (n¼137)ular traffic exposure,LIBCSP 1996–1997a.
High vehicular traffic (Z95th percentile)
Unmethylated (N) Methylated (N) OR (95%CI)
) 24 18 0.74(0.38, 1.45)
) 37 5 0.90(0.30, 2.65)
) 20 22 0.72(0.38, 1.40)
) 18 18 1.11(0.54, 2.25)
) 13 25 1.35(0.65, 2.80)
) 8 30 0.60(0.26, 1.42)
) 33 5 0.94(0.34, 2.57)
) 26 12 1.18(0.56, 2.15)
) 32 6 0.66(0.24, 1.78)
) 28 10 2.79(1.24, 6.30)
) 32 6 0.49(0.20, 1.23)
or post-college), income (o$34,999,$35,000–69,999, Z$70,000) and the matching
time alcohol intake (non-drinkers, o15 g/day).
A.J. White et al. / Environmental Research 145 (2016) 93–100 99(Pirouzpanah et al., 2010), which we did not observe when we
considered ever active smoking, which we specifically examined in
order to try and replicate this finding. Differences in active
smoking exposure history due to geographic and cultural differ-
ence between studies may, at least in part, explain this dis-
crepancy. Methylation levels may reflect both long-term and re-
cent exposures, so it is biologically plausible for variables reflect-
ing different time periods to both be relevant (Shenker et al.,
2013). Ever active smoking and current active smoking were as-
sociated with different methylation markers in this study, sug-
gesting that methylation may change after stopping smoking
(Tsaprouni et al., 2014) or that current smokers may represent
those with a higher intensity or longer duration of tobacco use and
thus may have different methylation patterns for that reason.
Other studies have focused on white blood cell methylation in
healthy individuals, although inconsistent associations between
air pollution and smoking with both gene-specific and global
methylation have been observed (Terry et al., 2011). However, it is
unclear whether global methylation measures accurately reflect
that of the target tissue (Brooks et al., 2009). Thus, as compared
with previous investigations, our study expands the specific re-
search questions addressed and the study approach, by utilizing a
larger population-based study population as well as broadening
the scope of the relevant PAH sources and DNA methylation tar-
gets considered.
We used a panel of a priori genes, and thus, this study cannot
rule out that there are other methylation sites which could be
relevant to PAHs and breast cancer. We did not adjust for multiple
comparisons; all comparisons made were driven by biologically
plausible hypotheses and we did not rely on statistical significance
for interpretation of measures of association and focused on
evaluating trends (Savitz and Olshan, 1995). However, we cannot
rule out that some of these associations may be due to chance,
because in our study there are some instances of low prevalence of
methylated genes and small within stratum sizes that produced
imprecise estimates and may have resulted in over fitting of the
models. Regarding generalizability, the women in the LIBCSP are
predominately white and postmenopausal (Gammon et al., 2002),
and therefore our results may not be applicable to all women.
In this first population-based study to report on gene-specific
methylation in association with current active smoking, residential
ETS, synthetic log burning, grilled/smoked meat intake and vehi-
cular traffic, we identified biologically plausible associations with
aberrant DNA methylation in the tumor tissue. DNA methylation
represents a potential biologic mechanism for environmental
chemicals, such as PAH, to influence breast cancer risk.Acknowledgments
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